Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GIPS-III metformin after primary PCI for ST-elevation myocardial infarction
2009-018162-34Phase 4Active
- Sponsor
- Thoraxcenter
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin in myocardial infarction (MI) (2 arms), sponsored by Thoraxcenter. Primary endpoint: Left ventricular ejection fraction at 4 months. Started Sep 2011; status: active.
02
Drugs
metformin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2009-018162-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018162-34.